Visualizing acute pain-morphine interaction in descending monoamine nuclei with Fos

Brain Research

Volumn 1306, Issue , 2010, Pages 29-38

  Bajic, Dusica ^a,b   Commons, Kathryn G ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brainstem; Formalin; Fos; Morphine; Pain; Rat

Indexed keywords

MORPHINE; MORPHINE SULFATE; PROTEIN FOS;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; NORADRENERGIC NERVE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAPHE MAGNUS NUCLEUS; RAT; SEROTONINERGIC NERVE CELL;

RATTUS;

EID: 71549116168     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.10.010     Document Type: Article

References (58)

1. Abbott F.V., Franklin K.B.J., and Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60 (1995) 91-102
2. Bardo M.T., Rowlett J.K., and Harris M.J. Conditioned place preference using opiate and stimulant drungs: a meta-analysis. Neurosci. Biobehav. Rev. 19 (1995) 39-51
3. Basbaum A.I., and Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7 (1984) 309-338
4. Bullitt E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J. Comp. Neurol. 296 (1990) 517-530
5. Burnett A., and Gebhart G.F. Characterization of descending modulation of nociception from the A5 cell group. Brain Res. 546 (1991) 271-281
6. Byrum C.E., and Guyenet P.G. Afferent and efferent connections of the A5 noradrenergic cell group in the rat. J. Comp. Neurol. 261 (1987) 529-542
7. Chance W.T., Krynock G.M., and Rosecrans J.A. Effects of medial raphe and raphe magnus lesions on the analgesic activity of morphine and methadone. Psychopharmacology (Berl.) 56 (1978) 133-137
8. Chang S.L., Squinto S.P., and Harlan R.E. Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 157 (1988) 698-704
9. Chen T., Dong Y.X., and Li Y.Q. Fos expression in serotonergic neurons in the rat brainstem following noxious stimuli: an immunohistochemical double-labelling study. J. Anat. 203 (2003) 579-588
10. Cicero J., Ennis T., Ogden J., and Meyer E.R. Gender differences in the reinforcing properties of morphine. Pharmaciol. Biochem. Behav. 65 (2000) 91-96
11. Clark F.M., and Proudfit H.K. The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry. Brain Res. 547 (1991) 279-288
12. Clark F.M., and Proudfit H.K. Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons. Brain Res. 591 (1992) 44-53
13. Clark F.M., and Proudfit H.K. The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Brain Res. 616 (1993) 200-210
14. Dragunow M., and Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods 29 (1989) 261-265
15. Drye R.G., Baisden R.H., Whittington D.L., and Woodruff M.L. The effects of stimulation of the A5 region on blood pressure and heart rate in rabbits. Brain Res. Bull. 24 (1990) 33-39
16. Du H.J., Kitahata L.M., Thalhammer J.G., and Zimmermann M. Inhibition of nociceptive neuronal responses in the cat's spinal dorsal horn by electrical stimulation and morphine microinjection in nucleus raphe magnus. Pain 19 (1984) 249-257
17. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brainstem stimulation in rats and cats. Pain 4 (1977) 161-164
18. Fang F., and Proudfit H.K. Spinal cholinergic and monoamine receptors mediate the antinociceptive effect of morphine microinjected in the periaqueductal gray on the rat tail, but not the feet. Brain Res. 722 (1996) 95-108
19. Fang F., and Proudfit H.K. Antinociception produced by microinjection of morphine in the rat periaqueductal gray is enhanced in the foot, but not the tail, by intrathecal injection of alpha1-adrenoceptor antagonists. Brain Res. 790 (1998) 14-24
20. Fields H.L., and Basbaum A.I. Central nervous system mechanisms of pain modulation. In: Wall P.D., and Melzack R. (Eds). Text Book of Pain (1999), Churchill Livingstone, London 309-329
21. Fields H.L., Heinricher M.M., and Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14 (1991) 219-245
22. Gao K., Chen D.O., Genzen J.R., and Mason P. Activation of serotonergic neurons in the raphe magnus is not necessary for morphine analgesia. J. Neurosci. 18 (1998) 1860-1868
23. Han F., Zhang Y.F., and Li Y.Q. Fos expression in tyrosine hydroxylase-containing neurons in rat brainstem after visceral noxious stimulation: an immunohistochemical study. World J. Gastroenterol. 9 (2003) 1045-1050
24. Heilig M., Engel J.A., and Soderpalm B. C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur. J. Pharmacol. 236 (1993) 339-340
25. Herdegen T., and Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28 (1998) 370-490
26. Herkenham M., and Pert C.B. Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality. J. Neurosci. 2 (1982) 1129-1149
27. Holden J.E., Schwartz E.J., and Proudfit H.K. Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha2-adrenoceptors. Neuroscience 91 (1999) 979-990
28. Hunt S.P., Pini A., and Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328 (1987) 632-634
29. Jones S. Descending control of nociception. In: Light A. (Ed). The Initial Processing of Pain and Its Descending Control: Spinal and Trigeminal Systems (1992), Karger, New York 203-295
30. Lang B., and Li Y.Q. Serotoninergic neurons in the brainstem expressing FOS protein after orofacial noxious stimulation: an immunocytochemical double-labeling study. J. Hirnforsch. 39 (1998) 263-268
31. Leah J.D., Herdegen T., and Zimmermann M. Physiological and pharmacological induction of c-fos protein immunoreactivity in superficial dorsal horn neurons. In: Cervero F., Bennett J.G., and Headley P.M. (Eds). Processing of Sensory Informaion in the Superficial Dorsal Horn of the Spinal Cord (1989), Plenum Press, New York 307-310
32. Light A.R. The Initial Processing of Pain and its Descending Control: Spinal and Trigeminal Systems Vol. 12 (1992), Karger, Basel
33. Liu J., Nickolenko J., and Sharp F.R. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8537-8541
34. Loewy A.D., Gregorie E.M., McKellar S., and Baker R.P. Electrophysiological evidence that the A5 catecholamine cell group is a vasomotor center. Brain Res. 178 (1979) 196-200
35. Loewy A.D., McKellar S., and Saper C.B. Direct projections from the A5 catecholamine cell group to the intermediolateral cell column. Brain Res. 174 (1979) 309-314
36. Loewy A.D., Marson L., Parkinson D., Perry M.A., and Sawyer W.B. Descending noradrenergic pathways involved in the A5 depressor response. Brain Res. 386 (1986) 313-324
37. Luccarini P., Childeric A., Gaydier A.M., Voisin D., and Dallel R. The orofacial formalin test in the mouse: a behvioral model for studying physiology and modulation of trigeminal nociception. J. Pain 7 (2006) 908-914
38. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7 (1987) 2445-2464
39. Mason P. Central mechanisms of pain modulation. Curr. Opin. Neurobiol. 9 (1999) 436-441
40. Miller J.F., and Proudfit H.K. Antagonism of stimulation-produced antinociception from ventrolateral pontine sites by intrathecal administration of alpha-adrenergic antagonists and naloxone. Brain Res. 530 (1990) 20-34
41. Morgan J.I., Cohen D.R., Hempstead J.L., and Curran T. Mapping pattern of c-fos expression in the central nervous system after seizure. Science 237 (1987) 192-197
42. Morgan M.M., Fossum E.N., Stalding B.M., and King M.M. Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat. J. Pain 7 (2006) 358-366
43. Omote K., Kawamata T., Kawamata M., and Namiki A. Formalin-induced nociception activates a monoaminergic descending inhibitory system. Brain Res. 814 (1998) 194-198
44. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, Orlando, FL
45. Persico A.M., Schindler C.W., O'Hara B.F., Brannock M.T., and Uhl G.R. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Brain Res. Mol. Brain Res. 20 (1993) 91-100
46. Proudfit H.K. Reversible inactivation of raphe magnus neurons: effects on nociceptive threshold and morphine-induced analgesia. Brain Res. 201 (1980) 459-464
47. Proudfit H.K. Effects of raphe magnus and raphe pallidus lesions on morphine-induced analgesia and spinal cord monoamines. Pharmacol. Biochem. Behav. 13 (1980) 705-714
48. Proudfit H.K., and Anderson E.G. Morphine analgesia: blockade by raphe magnus lesions. Brain Res. 98 (1975) 612-618
49. Rivot J.P., Chaouch A., and Besson J.M. The influence of naloxone on the C fiber response of dorsal horn neurons and their inhibitory control by raphe magnus stimulation. Brain Res. 176 (1979) 355-364
50. Romagnano M.A., Harshbarger R.J., and Hamill R.W. Brainstem enkephalinergic projections to spinal autonomic nuclei. J. Neurosci. 11 (1991) 3539-3555
51. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
52. Sharp F.R., Sagar S.M., and Swanson R.A. Metabolic mapping with cellular resolution: c-fos vs. 2-deoxyglucose. Crit. Rev. Neurobiol. 7 (1993) 205-228
53. Stanek K.A., Neil J.J., Sawyer W.B., and Loewy A.D. Changes in regional blood flow and cardiac output after l-glutamate stimulation of A5 cell group. Am. J. Physiol. 246 (1984) H44-51
54. Umino A., Nishikawa T., and Takahashi K. Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem. Int. 26 (1995) 85-90
55. Yaksh T.L. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res. 160 (1979) 180-185
56. Yaksh T.L., Plant R.L., and Rudy T.A. Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine. Eur. J. Pharmacol. 41 (1977) 399-408
57. Yeomans D.C., and Proudfit H.K. Antinociception induced by microinjection of substance P into the A7 catecholamine cell group in the rat. Neuroscience 49 (1992) 681-691
58. Yeomans D.C., Clark F.M., Paice J.A., and Proudfit H.K. Antinociception induced by electrical stimulation of spinally projecting noradrenergic neurons in the A7 catecholamine cell group of the rat. Pain 48 (1992) 449-461